Skip to content

SAMARA

Active Private limited companyfounded 2020active for 6 yearsGaverland 120, 9620 ZottegemKBO/BCE: BE 0750.804.447
SAMARA
Follow ReportCompare

Overview

Lifetime

6 annual accounts with figures on one time axis
peak €72,003 (2022)
€37,069▼ 20.0%
peak €47,197 (2022)
€1,940▼ 70.8%
peak €107,798 (2025)
€107,798▲ 1.8%
€99,241▲ 4.6%
Board1 name since 2020
1 directorVAN DE VELDE Els Anna
Documentsfilings and deeds
23-07-20268 days before the deadline
2025micro format
Gross margin from €46,364 to €37,069Result from €6,650 to €1,940

Key points

from the 2025 annual accounts

Equity

€107,798 ▲ 1.8%

SAMARA has made a profit in every financial year since 2020.

Turnover

≈ €110,000 estimated

The micro format states no turnover.

Position in the sector

€1,940

Lower net result than 90% of companies in human health. Sector median €60,070 · 20,754 companies.

Checked score

92
Excellent
Financially stronger than 38% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

77-1equity 52.1% of total assets
76-1short-term debt 47.9% · cash 80.1%
67-6return on assets 0.9%

Score breakdown

lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 1.68, cash €165,803
Size: total assets €207,038
Equity €107,798 (52.1% of total assets)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 42% of them on solvency, 58% on liquidity, 12% on profitability and 42% on growth.

The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 5,047 companies had the same profile as SAMARA has now. Each dot stands for 13 companies, two years later.

94.0%
were still trading
3.8%
stopped another way
2.2%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet

The bankruptcy probability of SAMARA itself is lower: < 0.1% within 12 months. It rests on far more data about SAMARA than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 5,047 companies, not a prediction for SAMARA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €9,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 1.68 (1.45 in 2024), above the usual 1.5. Short-term debt is 47.9% and cash 80.1% of total assets. 47.9% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

5 signals, none raises the risk
Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.68, cash €165,803
NBB · annual accounts
lowers risk · Size: total assets €207,038
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €107,798 (52.1% of total assets)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
8 days early
2024
14 days early
2023
5 days early
2022
14 days early
2021
6 days late
2020
14 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 6 accounts on average 8 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 23 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

VD
VAN DE VELDE Els Anna
Director, since 15-07-2020
  • VAN DE VELDE Els Anna 50 sharesdeed of 22-07-2020
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0750804447
Incorporation Founding capital of €5,000, 50 shares · Founder: VAN DE VELDE Els Anna · Appointment: VAN DE VELDE Els Anna (director) · published on 22-07-2020 · Gazette deed
First establishment Gaverland 120, Zottegem
All 12 events

Comparable companies

same main activity, similar in size and age
Company
SAMARA Zottegem €207,038 €37,069 52.1% -
Move2Health Oudenaarde €185,523 €45,722 3.1% -
Barbara Verstraeten Sint-Niklaas €249,470 €41,908 2.0% -
Patient Expert Center Zaventem €174,546 €38,995 58.0% -
SIVERMO Kruisem €165,119 €26,473 42.6% -
JA! Kortrijk €187,373 €43,610 44.1% -
CORVILAIN & CIE Namur €280,579 €41,336 6.6% -

These companies have the same main activity as SAMARA: nutrition and dietetics services (NACE 86995). They are comparable in size and age: total assets between €165,000 and €281,000, founded between 2019 and 2020.

Official details

Source: KBO
Status
Active since 17-07-2020Normal situation
Activity
Nutrition and dietetics servicesNACE 86995and 1 other
Establishment unit
2.306.412.8479620 Zottegem, since 17-07-2020
Financial year end
31 December
Peppol
Reachable since 06-11-2025
Company details

Annual accounts 2025

€37,069▼ 20.0%
€1,940▼ 70.8%
€107,798▲ 1.8%
€207,038▲ 3.1%
Filing
Filed on 23-07-2026, 8 days before the end of the filing period
Financials

Insights on SAMARA

SAMARA files the micro format. That format states no turnover. The gross margin rose from €5,569 in 2020 to €37,069 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

micro format, filed on 23-07-2026, 8 days before the deadline
€37,069
▼ 20.0%
€10,700
▼ 31.9%
€1,940
▼ 70.8%
€67,887
▲ 60.4%
52.1%
▼ 0.7 percentage points
1.68
▲ 0.24

Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.

Turnover ≈ €110,000. Estimated: probably between €85,000 and €160,000.

Balance sheet

balance sheet total €207,038 on 31-12-2025
What the company ownsHow it is paid for

in euro

in euro

Position in the sector

Compare with sector

52.1%

Higher than 41% of 20,767 companies in 2025.

1.68

Higher than 35% of 20,341 companies in 2025.

0.9%

Higher than 9% of 20,623 companies in 2025.

SAMARA Middle half of the sector 80% of the sector Micro accounts in human health (NACE 86)

Net result: bottom quarter · Equity: middle half · Balance sheet total: middle half · Working capital: middle half

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023202220212020
Balance sheet: assets
20/58 207,038200,739198,592163,509110,60860,728
20 0111328544761977
21/28 39,91163,42788,66035,44732,15741,257
22/27 39,91163,42788,66035,44732,15741,257
23 4,23010,74622,20133,97832,15741,257
24 35,68152,68066,4591,469--
29/58 167,127137,201109,604127,51877,69118,494
40/41 1,0791,472053608,225
40 --0536--
41 1,0791,472--08,225
54/58 165,803135,469108,050126,01576,9359,525
490/1 2462611,554967756744
Balance sheet: equity and liabilities
10/49 207,038200,739198,592163,509110,60860,728
10/15 107,798105,85899,20889,98942,7915,305
10/11 5,0005,0005,0005,0005,0005,000
13 100,000-----
133 100,000-----
14 2,798100,85894,20884,98937,791305
17/49 99,24194,88199,38473,52067,81755,422
17 -05,64713,93121,99729,850
170/4 -05,64713,93121,99729,850
42/48 99,24194,88193,73759,59045,82025,572
42 05,6478,2838,0667,8547,647
44 2071624,6283,2639061,925
440/4 2071624,6283,2639061,925
45 5,3785,3047,67617,13211,7081,532
450/3 5,3785,3047,41517,13211,2081,532
454/9 -02620500-
47/48 93,65683,76873,14931,12925,35214,468
Income statement
9900 37,06946,36442,71672,00354,5935,569
630 25,13229,00225,82411,2299,3174,349
640/8 1,2361,645859122198-
9901 10,70015,71616,03460,65245,0781,220
75/76B 0--001
75 0--001
65/66B 6,3676,5383,5421,9701,848915
65 6,3676,5383,5421,9701,848915
9903 4,3339,17812,49258,68143,230305
67/77 2,3932,5283,27311,4845,744-
9904 1,9406,6509,21947,19737,486305
9905 1,9406,6509,21947,19737,486305
Appropriation of the result
9906 102,798100,85894,20884,98937,791305
14P 100,85894,20884,98937,791305-
691/2 100,000-----
6921 100,000-----
Document PDFPDFPDFPDFPDFPDF

The notes to these accounts have 9 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 23-07-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 micro format 23-07-2026 2026-00322538 PDF
31-12-2024 micro format 17-07-2025 2025-00282499 PDF
31-12-2023 micro format 26-07-2024 2024-00289970 PDF
31-12-2022 micro format 17-07-2023 2023-00242796 PDF
31-12-2021 micro format 06-08-2022 2022-20274345 PDF
31-12-2020 micro format 17-07-2021 2021-37400512 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023202220212020
35,83344,71841,85871,88154,3955,569
27,07235,65235,04358,42746,8034,654
1,5063,55278,82114,30321745,500
30,33427,419-17,96549,08167,410-
67,88742,32015,86767,92831,871-7,078
52.1%52.7%50.0%55.0%38.7%8.7%
1.681.451.172.141.700.72
0.920.901.000.821.5810.45
1.8%6.3%9.3%52.4%87.6%5.8%
0.9%3.3%4.6%28.9%33.9%0.5%
5.636.8411.8236.4829.44-

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Investments

fixed assets acquired
Item20252024202320222021
Tangible fixed assets€1,506€3,552€78,821€14,303-
Financial fixed assets€0----
€25,132€29,002€25,824€11,229€9,317

Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)

Insights on SAMARA

The operating result for 2025 is 32% lower than in 2024 and the lowest since 2020. It is the third fall in a row.

Debt's share of the balance-sheet total rises from 47.3% to 47.9%. Equity and debt are higher.

Board & ownership

Board

1 director, since incorporation
VAN DE VELDE Els Anna
Director
since 15-07-2020 term without a fixed end
listed in the 2025 annual accounts, filed on 23-07-2026
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 22-07-2020

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today
VAN DE VELDE Els Anna
Director
Board
Mandates as a list
  • VAN DE VELDE Els Anna
    • Director, from 15-07-2020 to date

See the board, name and registered office on a given date →

Control

Founder
VAN DE VELDE Els Anna
This company
SAMARA
Equity €107,798
Profit €1,940 in 2025

Capital

Contribution
€5,000
Shares
50
Contribution per share
€100
Equity per share
€2,156 in 2025
Source
deed of 22-07-2020

Articles of association

deed of 22-07-2020 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Friday of June at 18:00

Shareholders

At incorporation deed of 22-07-2020 ↗

Network & group

No group

SAMARA has no parent and no holdings in its annual accounts. VAN DE VELDE Els Anna is the only director. SAMARA shares no director with another company.

Timeline

Timeline

12 events since 2020

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBmicro format · 8 days before the deadline
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0750804447
Annual accounts 2024 filed PDFmicro format · 14 days before the deadline
2024
Equity above €100,000 equity €105,858 ▲6.7% With a profit in every financial year since 2020, equity grows to €105,858.
Annual accounts 2023 filed PDFmicro format · 5 days before the deadline
2023
Annual accounts 2022 filed PDFmicro format · 14 days before the deadline
2022
Highest result from 2020 to 2025 net €47,197 ▲25.9% The operating result of €60,652 and the net result of €47,197 are both a record.
Annual accounts 2021 filed PDFmicro format · 6 days late
2021
Liquidity more than doubled current ratio 1.70 The current ratio rises from 0.72 to 1.70.
Annual accounts 2020 filed PDFmicro format · 14 days before the deadline
2020
IncorporationFounding capital of €5,000, 50 shares · Founder: VAN DE VELDE Els Anna · Appointment: VAN DE VELDE Els Anna (director) · published on 22-07-20203 points ▸

Open the deed in the Belgian Official Gazette

First establishment Gaverland 120, Zottegem

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

SAMARA was incorporated on 17 July 2020 as a private limited company by one natural person, with a starting capital of €5,000.12 Since 2020, VAN DE VELDE Els Anna has served as director.3 Total assets rose from €60,728 in 2020 to €207,038 in 2025.4

  1. 1KBO register
  2. 2Belgian Official Gazette, 22-07-2020
  3. 3National Bank, annual accounts 2025
  4. 4National Bank, annual accounts 2020 and 2025

Company details

Identity

Enterprise number
0750.804.447
VAT number
BE 0750.804.447
Peppol ID
0208:0750804447
Other Peppol ID
9925:BE0750804447
Legal form
Private limited company
Status
Active, normal situation
Founded
17-07-2020
Financial year
ends on 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Third Friday of June at 18:00
deed of 22-07-2020 (in Dutch)
Peppol
Reachable since 06-11-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
SAMARA in Dutch
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 22-07-2020 (in Dutch)
Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
“Vlaams Gewest”
deed of 22-07-2020 (in Dutch)

Activities

NACEBEL 2025
86995 Nutrition and dietetics services main activity
46150 Agents in the wholesale of furniture, household goods and hardware
Codes under NACEBEL 2008
86909 Human health activities main activity
46150 Wholesale trade
PurposeThe purpose describes the activities the company may carry out under its articles.
“Uitvoeren van huidverzorging en permanente ontharing alsmede alles wat daarop hoegenaamd betrekking heeft,in de ruime zin van het woord; De…”
6 activities
  1. Uitvoeren van huidverzorging en permanente ontharing alsmede alles wat daarop hoegenaamd betrekking heeft,in de ruime zin van het woord
  2. De aan- en verkoop van producten en artikelen die betrekking hebben op huidverzorging en permanente ontharing.
  3. Verlenen van advies en diensten op het gebied van huidverzorging en permanente ontharing.
  4. De vennootschap handelt voor eigen rekening,in consignatie,in commissie als tussenpersoon of als vertegenwoordiger.
  5. De vennootschap mag tevens de functie van bestuurder,vereffenaar of gemandateerde waarnemen evenals elke directiefunctie in ondernemingen.
  6. De vennootschap is gerechtigd alle industriële-,handels-,financiële-.roerende en onroerende handelingen te verrichten die rechtstreeks of onrechtstreeks bij het voorwerp aansluiten of er de verwezenlijking van kunnen bevorderen;zij mag alle verbintenissen aangaan,kredieten en leningen toestaan,zich voor derden borg stellen door haar goederen in hypotheek of in pand te geven,inclusief de eigen handelszaak.
deed of 22-07-2020 (in Dutch)

Registered office and establishments

1 establishment
Establishment Since Unit number
Gaverland 120 registered office 9620 Zottegem 4618031 Agents specialised in the wholesale of other particular products 17-07-2020 2.306.412.847

Buildings and parcels at the address

Ground area
535 m²
Buildings
120 m²
Volume, LiDAR
928 m³
Tallest building
10.6 m
Buildings to scale, each on its own parcel
120 m², 10.6 m 120 m², 10.6 m

Location

registered office establishment The establishment unit on the map

Parcels

Cadastral parcelArea Buildings Height / floors
41017B0672/00L000535 m² 1 · 120 m² 10.6 m · 3

We would like to set cookies. That happens only with your consent. What we measure